NCT02917876

Brief Summary

This study seeks to understand the physical, physiologic and biologic features that predispose a woman to the development of obstructive sleep apnea once they are exposed to the cardiopulmonary and metabolic physiological changes of pregnancy. Knowing these specific predictive factors can help identify a population at risk and guide clinicians to develop suitable targeting screening strategies.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
450

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 21, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 28, 2016

Completed
1 month until next milestone

Study Start

First participant enrolled

November 1, 2016

Completed
7.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2023

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
Last Updated

November 22, 2024

Status Verified

November 1, 2024

Enrollment Period

7.2 years

First QC Date

September 21, 2016

Last Update Submit

November 20, 2024

Conditions

Keywords

Obstructive Sleep ApneaPregnancyObesityFluid shiftsBody compositionSleep

Outcome Measures

Primary Outcomes (1)

  • Characteristics of participants who develop obstructive sleep apnea defined as an apnea hypopnea index >5 events per hour

    The study will develop a model of biologic, physiologic and anthropometric measures that predict the development of obstructive sleep apnea apnea later in pregnancy compared to baseline in early pregnancy.

    Up to 40 weeks

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Pregnant women, 18 years or older, at less than 13 completed weeks of gestation and who have a BMI that is greater than 30 kg/m2 at recruitment.

You may qualify if:

  • \<13 completed weeks of gestation
  • BMI \>30 kg/m2 at recruitment
  • \>18 years of age
  • Ability to give informed consent

You may not qualify if:

  • Twin pregnancies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Miriam Hospital

Providence, Rhode Island, 02904, United States

Location

Related Publications (2)

  • Bublitz MH, Nillni Y, Nugent NR, Sanapo L, Habr N, Bourjeily G. Posttraumatic stress disorder, diurnal cortisol, and ambulatory blood pressure in early and late pregnancy. J Trauma Stress. 2023 Feb;36(1):239-246. doi: 10.1002/jts.22895. Epub 2022 Dec 4.

  • Sanapo L, Bublitz MH, Bai A, Mehta N, Messerlian GM, Catalano P, Bourjeily G. Association between sleep disordered breathing in early pregnancy and glucose metabolism. Sleep. 2022 Apr 11;45(4):zsab281. doi: 10.1093/sleep/zsab281.

Biospecimen

Retention: SAMPLES WITH DNA

Blood samples will be stored for future testing

MeSH Terms

Conditions

Sleep Apnea, ObstructiveObesity

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Ghada Bourjeily, MD

    The Miriam Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Medicine

Study Record Dates

First Submitted

September 21, 2016

First Posted

September 28, 2016

Study Start

November 1, 2016

Primary Completion

December 30, 2023

Study Completion

May 1, 2025

Last Updated

November 22, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will share

De-identified data for primary and secondary outcome measures will be made available.

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
Data will be available within 12 months of study completion.
Access Criteria
Investigators data access requests will be reviewed by an independent review committee. Requestors will need to sign a data access agreement.

Locations